Fol. Biol. 2014, 60, 83-88
https://doi.org/10.14712/fb2014060020083
MTHFR and HFE, but Not Preproghrelin and LBP, Polymorphisms as Risk Factors for All-Cause End-Stage Renal Disease Development
Individual author index pages
Other articles of these authors
-
Genetics of T2DM and Its Chronic Complications: Are We Any Closer to the Individual Prediction of Genetic Risk?
D. Galuška, Lucie Dlouhá, J. A. Hubáček, K. Kaňková
2022, Vol. 68, Issue 5-6, pp. 159-179 -
Genetic Markers at ANRIL, FTO and 2q36.3 Locus in Czech Patients Undergoing Coronary Artery Bypass Graft Surgery
Petr Kačer, J. Pirk, V. Lánská, J. A. Hubáček, V. Adámek, T. Červinková, J. Bělohoubek, O. Auzký, V. Adámková
2020, Vol. 66, Issue 4, pp. 148-153 -
Strong Association between APOA5 Gene Polymorphisms and Hypertriglyceridaemic Episodes
Michal Vrablík, J. A. Hubáček, D. Dlouha, M. Satny, V. Adámková, R. Ceska
2019, Vol. 65, Issue 4, pp. 188-194 -
Can Leukocyte Telomere Length Predict Survival Time in Heart Transplant Recipients over a Minimal Follow-Up of 20 years?
Dana Dlouhá, V. Vančura, J. Vymětalová, J. A. Hubáček, V. Lánská, I. Málek
2016, Vol. 62, Issue 5, pp. 188-193 -
Polymorphisms in IFN-γ, TNF-α and IL-10 in Patients on Maintenance Haemodialysis
Silvie Bloudíčková, L. Kuthanová, J. A. Hubáček
2011, Vol. 57, Issue 1, pp. 30-34 -
Why We Are Not Able to Find the Coronary Heart Disease Gene – apoE As an Example
Rudolf Poledne, J. A. Hubáček, V. Staněk, M. Aschermann, J. Matoušková, J. Veselka, P. Widimský, R. Cífková, V. Lánská, J. Piťha
2010, Vol. 56, Issue 5, pp. 218-222
